Skip to main content

The PD-1/PD-L1 pathway

Limiting damage to healthy tissue

Inactivation of T cells limits damage to healthy tissue.

The tumor escapes detection

Inactivation of T cells reduces tumor cell killing

Immuno-oncology therapies harness the immune response to fight tumors

Blocking PD-L1 enables cytotoxic T cells to actively remove tumor cells

Want to hear more about PD-L1 IHC 28-8 pharmDx?

Contact your local sales representative